SELECT-AXIS 1: UPA 15 mg QD consistently efficacious over 2 years for ASAS40. Low radiographic progression rates in AS pts. No new safety findings were observed. Abs 0924 #ACR21 #RheumNow @RheumNow https://t.co/CWvH1OPGyR https://t.co/uC67fJZDCE
Links:
Efficacy and Safety of Upadacitinib in Patients with Active Ankylosing Spondyli…
http://ow.ly/tH7R50Gt7OC
07-11-2021